Search results
Hims & Hers is selling an Ozempic knockoff without FDA approval. Here's how
Quartz· 3 days agoThe millennial-skewed telehealth platform Hims & Hers this week joined several online pharmacies in...
Viatris Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 2 days agoViatris Inc (NASDAQ:VTRS) recently announced a dividend of $0.12 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-23. As...
TikToker Remi Bader Reveals Before-and-After of Fitness Transformation After Quitting Ozempic - E!...
E! Online· 6 hours agoA year after revealing she quit using drug Ozempic to lose weight, TikToker star Remi Bader shared...
AbbVie prevails in suit alleging payoffs to generic manufacturers
Crain s Chicago Business· 7 days agoA U.S. appeals court has dismissed a complaint against AbbVie and its subsidiary Allergan, which were accused of using "unlawful 'reverse' settlement payments" to keep generic
GlaxoSmithKline Pharma India posts higher Q4 adjusted profit on strong sales
Reuters via Yahoo Finance· 7 days agoRevenue from operations rose 18% to 9.30 billion rupees, led by a 12% growth in its generic medicines portfolio which the company attributed to key focus ...
Congress evaluate how to lower prescription prices by increasing competition
WJAX via Yahoo News· 3 days agoMedical experts say competition is key. They say big pharma has a limited period to sell a new drug...
Congress evaluate how to lower prescription prices by increasing competition
WPXI via Yahoo News· 3 days agoMedical experts say competition is key. They say big pharma has a limited period to sell a new drug...
Senators Mull Ways to Stop Patent 'Abuse' by Pharma Companies
MedPage Today· 3 days agoSenators and experts on Tuesday examined the range of tools that brand-name drug manufacturers have...
House Members Question FDA Officials on Lab-Developed Tests, Missed Deadlines
MedPage Today· 2 days agoWith all the news about drug shortages, there's another type of possible shortage that the public...
Hims debuts $199 weight-loss shots, takes aim at Lilly's Zepbound - Indianapolis Business Journal
Indianapolis Business Journal· 4 days agoIn just a few years, Hims & Hers Health Inc. reached almost $1 billion in sales by making it easy to...